Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.60 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.60 |
| ▸ | TST | Q16762 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PRKCA | P17252 | 9/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL874725 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL15364 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL16950234 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL936066 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL875292 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL1503121 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL16201 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL875399 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL22730055 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL | |
| SCHEMBL875356 | 1.00 | MAPT (0.60) | MAPTHSPD1HSPE1TSTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 770 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12575581-B2 | Barrier coating compositions, wash compositions, and other compositions for perishables and methods, systems, kits and coated items relating thereto | COMESTAAG LLC (US) | 2026-03-17 | — | — | US | claimed |
| US-12512274-B2 | Wet electrolytic capacitor containing a gelled working electrolyte | KYOCERA AVX Components Corporation (US) | 2025-12-30 | — | — | US | claimed |
| US-20250352532-A1 | REDUCED NITROSAMINE FORMATION IN PHARMACEUTICAL COMPOSITIONS COMPRISING METHYLPHENIDATE | MEDICE ARZNEIMITTEL PUETTER GMBH & CO KG (DE) | 2025-11-20 | — | — | US | claimed |
| EP-4649943-A1 | REDUCED NITROSAMINE FORMATION IN PHARMACEUTICAL COMPOSITIONS COMPRISING METHYLPHENIDATE | Medice Arzneimittel Pütter GmbH & Co. KG (DE) | 2025-11-19 | — | — | EP | claimed |
| EP-4578035-A1 | WET ELECTROLYTIC CAPACITOR CONTAINING A GELLED WORKING ELECTROLYTE | KYOCERA AVX Components Corporation (US) | 2025-07-02 | — | — | EP | claimed |
| CN-120035876-A | Wet electrolytic capacitor comprising gelled working electrolyte | 京瓷AVX元器件公司 | 2025-05-23 | — | — | CN | claimed |
| US-20250090547-A1 | EPA-EE LIPID NANOCOMPOSITE, FORMULATION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2025-03-20 | — | — | US | claimed |
| CN-119523949-A | Inflammatory response type drug-loaded microgel system with slow release characteristic | 华中科技大学 | 2025-02-28 | — | — | CN | claimed |
| US-12213982-B2 | Pharmaceutical compositions comprising sepiapterin and uses thereof | PTC THERAPEUTICS MP, INC. (US) | 2025-02-04 | — | — | US | claimed |
| CN-119331144-A | Catalyst component for olefin polymerization, catalyst and application thereof | 中国石油天然气股份有限公司 | 2025-01-21 | — | — | CN | claimed |
| WO-1997010808-A1 | LIPOIC ACID IN TOPICAL COMPOSITIONS | PERRICONE NICHOLAS V (US) | 1997-03-27 | — | — | WO | claimed |
| US-5601810-A | MIXTURE OF PROTEIN, VEGETABLE WAX, VITSMINS AND WATER | CHANEL, INC. (US) | 1997-02-11 | — | — | US | claimed |
| EP-0710478-B1 | Composition for topical application containing a lipase and an active agent precursor | OREAL (FR) | 1997-01-22 | — | — | EP | claimed |
| US-5574063-A | Method and compositions for topical application of ascorbic acid fatty acid esters for treatment and/or prevention of skin damage | N.V. PERRICONE LLC | 1996-11-12 | — | — | US | claimed |
| US-5571503-A | AQUEOUS EMULSION, PLANT EXTRACTS, PHOSPHOLIPIDS, FREE RADICAL SCAVENGERS | CHANEL, INC. | 1996-11-05 | — | — | US | claimed |
| US-5545398-A | Method and compositions for topical application to the skin of tocotrienol for prevention and/or treatment of skin damage | N.V. PERRICONE LLC | 1996-08-13 | — | — | US | claimed |
| WO-1996019214-A1 | METHOD AND COMPOSITIONS FOR TOPICAL APPLICATION OF TOCOTRIENOL TO THE SKIN | PERRICONE NICHOLAS V (US) | 1996-06-27 | — | — | WO | claimed |
| US-5409693-A | Method for treating and preventing sunburn and sunburn damage to the skin | N.V. PERRICONE LLC | 1995-04-25 | — | — | US | claimed |
| US-5376361-A | Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage | N.V. PERRICONE LLC | 1994-12-27 | — | — | US | claimed |
| EP-0607642-A1 | Compositions for topical application to the skin for treatment and/or prevention of radiation-induced skin damage | PERRICONE, Nicholas V., Dr. (US) | 1994-07-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12512274-B2 | Wet electrolytic capacitor containing a gelled working electrolyte | DCLK1, DCLK3, SLC9A2 | MAPT 2873/4885HSPD1 1604/4885HSPE1 1972/4885 |
| US-12575581-B2 | Barrier coating compositions, wash compositions, and other compositions for perishables and methods, systems, kits and coated items relating thereto | CUTA, GK, WASHC4 | MAPT 3124/4885HSPD1 2669/4885HSPE1 3799/4885 |
| US-12213982-B2 | Pharmaceutical compositions comprising sepiapterin and uses thereof | SPR, PCSK9, SLC6A7 | MAPT 261/4885HSPD1 3324/4885HSPE1 3853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.